Interventional Cardiology

This cardiac subspecialty uses minimally invasive, catheter-based technologies in a cath lab to diagnose and treat coronary artery disease (CAD). The main focus in on percutaneous coronary interventions (PCI) to revascularize patients with CAD that is causing blockages resulting in ischemia or myocardial infarction. PCI mainly consists of angioplasty and implanting stents. Interventional cardiology has greatly expanded in scope over recent years to include a number of transcatheter structural heart interventions.

FDA clears TAVR guidewire built with BASILICA in mind
The Telltale system was designed to assist cardiologists when BASILICA is required prior to TAVR.
New technique could help when cardiologists repair 2 leaky heart valves at once
Performing M-TEER and T-TEER on the same patient using a single guide catheter appears to be both safe and effective. Researchers shared their experience with this approach in Circulation: Cardiovascular Interventions.
‘Strongest growth in over a decade’: Heart tech helps Medtronic beat earnings expectations
The company's PFA and TAVR technologies both played key roles in the successful second quarter. In addition, Medtronic expects its place in the renal denervation market to make a major impact going forward.
Did Boston Scientific pull the plug too early on TAVR devices? Cardiologists weigh in
Boston Scientific stopped selling its Acurate TAVR systems after they underperformed in a few key trials and failed to gain FDA approval. Was it the right call?
New physician Medicare payments for the Agent drug-coated balloon set for 2027
Boston Scientific said two category III CPT codes are set to become permanent category I codes for physician payments starting Jan. 1, 2027.

Adopting a clopidogrel-based DAPT strategy after PCI boosts outcomes for heart attack patients

Patients given clopidogrel plus aspirin faced a lower risk of adverse events than those given ticagrelor plus aspirin.

PCI underused among NSTEMI patients with prior CABG

The new study, published in the Journal of the American Heart Association, focused on nearly 290,000 NSTEMI patients.

Many PAD patients are missing out on vital risk assessments

The findings, based on Medicare data, were presented at VIVA21 in Las Vegas.

First patient treated with CSI’s new peripheral support catheter

A vascular surgeon in Nashville performed the procedure, praising the device's "balance of support and flexibility."

How ITA harvesting techniques during CABG affect long-term outcomes

The new analysis, published in JAMA Cardiology, included data from 28 different facilities.

Major bleeding linked to adverse outcomes among patients with AFib and CAD

The study included patients with a recent history of PCI, CABG or confirmed coronary artery disease that did not require revascularization.

Picard Medical acquires mechanical heart replacement specialists

Picard Medical is a portfolio company of Hunniwell Lake Ventures, a California-based venture capital firm focused on healthcare technology.

Guided antiplatelet therapy a 'safe and attractive' treatment option for many UIA patients

Platelet function monitoring–guided antiplatelet therapy before stent placement provided patients with significant value.

Interventional Cardiology

FDA clears TAVR guidewire built with BASILICA in mind

New technique could help when cardiologists repair 2 leaky heart valves at once

‘Strongest growth in over a decade’: Heart tech helps Medtronic beat earnings expectations

Did Boston Scientific pull the plug too early on TAVR devices? Cardiologists weigh in

New physician Medicare payments for the Agent drug-coated balloon set for 2027